Interpretation of the NCCN clinical practice guidelines in oncology: Lung cancer screening (version 2.2024)
- VernacularTitle:2024年第2版《NCCN肿瘤临床实践指南—肺癌筛查》更新解读
- Author:
Dong DONG
1
;
Yajie ZHANG
1
;
Hecheng LI
1
Author Information
1. Department of Thoracic Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China
- Publication Type:Journal Article
- Keywords:
Lung cancer;
screening;
guideline;
interpretation
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2024;31(09):1253-1257
- CountryChina
- Language:Chinese
-
Abstract:
The National Comprehensive Cancer Network (NCCN) updates the "NCCN clinical practice guidelines in oncology: Lung cancer screening" annually, and the second edition of 2024 was released in October 2023. The 2024 edition of the guidelines builds on the 2023 edition with some updates on description and assessment of risk factors for lung cancer, evaluation and follow-up of lung nodules found during initial and subsequent screening, and low-dose CT screening protocols and imaging modalities. In this article, we will introduce the above updates and provide reference for lung cancer screening in China by combining the relevant guidelines and consensus in China.
